New therapeutic avenue in the fight against chronic liver disease

by Ulsan National Institute of Science and TechnologySchematic image showing the ETP expression and survival rate in liver tissue from HCC patients. Credit: UNISTAn international team of research

Updated on: April 10,2024 18

New therapeutic avenue in the fight against chronic liver disease

by Ulsan National Institute of Science and TechnologySchematic image showing the ETP expression and survival rate in liver tissue from HCC patients. Credit: UNISTAn international team of research

Updated on:April 10,2024 18

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer

Updated on: March 12,2024 17

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer

Updated on:March 12,2024 17

Researchers gain structural insights into the immune modulator Siglec-15 and its interaction with T cells

by CIC bioGUNEa Cartoon and surface representation of two views of the crystal structure of Siglec-15 in complex with anti-Siglec-15 5G12 Fab. 5G12 is composed of a heavy chain (HC) (in orange) and a

Updated on: February 18,2024 17

Researchers gain structural insights into the immune modulator Siglec-15 and its interaction with T cells

by CIC bioGUNEa Cartoon and surface representation of two views of the crystal structure of Siglec-15 in complex with anti-Siglec-15 5G12 Fab. 5G12 is composed of a heavy chain (HC) (in orange) and a

Updated on:February 18,2024 17

Research finds cancer immunotherapy does not interfere with COVID-19 immunity

bySaint Louis UniversityCredit: Unsplash/CC0 Public DomainResearch findings published inFrontiers in Immunologyshow that cancer immunotherapy does not interfere with COVID-19 immunit

Updated on: January 23,2024 15

Research finds cancer immunotherapy does not interfere with COVID-19 immunity

bySaint Louis UniversityCredit: Unsplash/CC0 Public DomainResearch findings published inFrontiers in Immunologyshow that cancer immunotherapy does not interfere with COVID-19 immunit

Updated on:January 23,2024 15

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin

Updated on: February 03,2024 16

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin

Updated on:February 03,2024 16

Comparison of survival times of advanced cancer patients with palliative care at home and in hospital

byUniversity of TsukubaCredit: AI-generated imageThe location where cancer patients spend their last days can affect their "quality of death." However, it remains unclear whether the l

Updated on: January 08,2024 12

Comparison of survival times of advanced cancer patients with palliative care at home and in hospital

byUniversity of TsukubaCredit: AI-generated imageThe location where cancer patients spend their last days can affect their "quality of death." However, it remains unclear whether the l

Updated on:January 08,2024 12

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on: April 22,2024 20

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on:April 22,2024 20

Treat cancer with cold plasma? Aerospace engineer helps bring first clinical trial

by Kayla Wiles,Purdue UniversityPurdue aerospace engineer Alexey Shashurin assisted in the development of the Canady Helios Cold Plasma System and Scalpel, which has been approved by the FDA for

Updated on: May 11,2024 8

Treat cancer with cold plasma? Aerospace engineer helps bring first clinical trial

by Kayla Wiles,Purdue UniversityPurdue aerospace engineer Alexey Shashurin assisted in the development of the Canady Helios Cold Plasma System and Scalpel, which has been approved by the FDA for

Updated on:May 11,2024 8

Researchers discover cancer hijacks a class of enzyme motif mutations to fuel tumorigenesis

byUniversity of North Carolina at Chapel Hill School of MedicineCredit: Pixabay/CC0 Public DomainCancer spreads throughout the human body in cunning, almost militaristic, ways. For example, it c

Updated on: January 30,2024 15

Researchers discover cancer hijacks a class of enzyme motif mutations to fuel tumorigenesis

byUniversity of North Carolina at Chapel Hill School of MedicineCredit: Pixabay/CC0 Public DomainCancer spreads throughout the human body in cunning, almost militaristic, ways. For example, it c

Updated on:January 30,2024 15

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh

Updated on: January 07,2024 9

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh

Updated on:January 07,2024 9

New major survey finds 'healthy' suntan myths persist despite warnings about skin cancer and aging

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainAmong Europeans, 8 in 10 believe tans are attractive, with almost as many (73%) saying tans are healthy, according to a new s

Updated on: February 01,2024 20

New major survey finds 'healthy' suntan myths persist despite warnings about skin cancer and aging

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainAmong Europeans, 8 in 10 believe tans are attractive, with almost as many (73%) saying tans are healthy, according to a new s

Updated on:February 01,2024 20

Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

by Impact Journals LLCApoptosis induction by DPDT. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28465A new research paper has been published in the journalOncotargetentitled, &q

Updated on: February 18,2024 14

Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

by Impact Journals LLCApoptosis induction by DPDT. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28465A new research paper has been published in the journalOncotargetentitled, &q

Updated on:February 18,2024 14